Steroid treatment of acute graft versus host disease grade I: a randomized trial.

about

Steroid treatment of acute graft versus host disease grade I: a randomized trial.

Item

http://www.wikidata.org/entity/Q41991743

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Steroid treatment of acute graft versus host disease grade I: a randomized trial.

@en

type

Item

label

Steroid treatment of acute graft versus host disease grade I: a randomized trial.

@en

prefLabel

Steroid treatment of acute graft versus host disease grade I: a randomized trial.

@en

P1476

Steroid treatment of acute graft-versus-host disease grade I: a randomized trial

@en

P2093

Alessandra Cupri

http://www.w3.org/2001/XMLSchema#string

Andrea Bacigalupo

http://www.w3.org/2001/XMLSchema#string

Anna Maria Raiola

http://www.w3.org/2001/XMLSchema#string

Antonio Risitano

http://www.w3.org/2001/XMLSchema#string

Antonio Severino

http://www.w3.org/2001/XMLSchema#string

Carmine Selleri

http://www.w3.org/2001/XMLSchema#string

Daniela Massi

http://www.w3.org/2001/XMLSchema#string

Franca Fagioli

http://www.w3.org/2001/XMLSchema#string

Francesca Bonifazi

http://www.w3.org/2001/XMLSchema#string

Francesca Gualandi

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry.

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.

How I treat refractory acute GVHD.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

P304

2125-2133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2017.171157

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Alessio Signori

Giuseppe Milone

M P Sormani

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28971905

http://www.w3.org/2001/XMLSchema#string

P932

5709112

http://www.w3.org/2001/XMLSchema#string